Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes

Cancer Genet Cytogenet. 2007 Jul 1;176(1):80-8. doi: 10.1016/j.cancergencyto.2007.03.009.

Abstract

We report two cases of translocation associated with deletion on derivative chromosomes in atypical myeloproliferative disorder (MPD). In a MPD with t(3;12)(q29;q14), the rearrangement targeted the HMGA2 locus at 12q14 and deleted a region of about 1.5 megabases (Mb) at 3q29. In an MPD with t(9;12)(q13 approximately q21;q22) and JAK2 V617F mutation, array comparative genomic hybridization delineated a deletion of about 3 Mb at 9q13 approximately q21 and a deletion of about 2 Mb at 12q22 containing SOCS2. These results show that close examination of translocations in hematopoietic diseases may reveal associated microdeletions. The role of these deletions is discussed.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Chromosomes, Human, Pair 12*
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 9
  • HMGA2 Protein / genetics*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / genetics*
  • Oligonucleotide Array Sequence Analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Suppressor of Cytokine Signaling Proteins / genetics*
  • Translocation, Genetic*

Substances

  • HMGA2 Protein
  • SOCS2 protein, human
  • Suppressor of Cytokine Signaling Proteins